Oral Gastric Suctioning Effect on Transesophageal Echo

NCT ID: NCT07209293

Last Updated: 2025-10-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-10-22

Study Completion Date

2026-10-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

During heart surgery images of the heart are taken with transesophageal echocardiography. The images track how the heart is doing during surgery. It is normal practice to place an oral gastric tube in the stomach during heart surgery. The oral gastric tube is used to suction out stomach contents to avoid potential aspiration and avoid stomach acid build up. The purpose of this research study is to see if the images of the heart have better quality after your stomach has been emptied. This project hopes to help determine the best method to obtain the better quality images of the heart during cardiac surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

After induction, the transesophageal echocardiography (TEE) probe will be placed in the usual fashion for the cardiac surgery case. Five specific images that are part of a standard TEE exam will be obtained by TEE. An oral gastric (OG) tube will then be placed to suction stomach contents. The OG tube will then be removed and the same five images previously taken will be repeated. The five images reviewed from the TEE include mid esophageal four chamber, mid esophageal two chamber, transgastric basal, transgastric mid-papillary and deep transgastric. Two blinded and independent cardiologists who are echocardiography experts will review the before and after images and grade them for quality of the images. They will grade the images on a scale of 1-4 with 1 being excellent quality and 4 being very poor quality.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

TEE Image Quality

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cardiac Surgery with Transesophageal Echocardiography

Participants scheduled for cardiac surgery with transesophageal echocardiography performed as part of their standard of care treatment during their surgery.

Transesophageal Echocardiography

Intervention Type DIAGNOSTIC_TEST

Transesophageal echocardiography images will be taken prior to and post oral gastric suction.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Transesophageal Echocardiography

Transesophageal echocardiography images will be taken prior to and post oral gastric suction.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- Transesophageal echocardiography assisted cardiac surgery

Exclusion Criteria

* hiatal hernia
* documented or suspected esophageal stricture
* contraindications to a TEE
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Wake Forest University Health Sciences

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Scott Coleman, DO

Role: PRINCIPAL_INVESTIGATOR

Wake Forest University Health Sciences

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Atrium Health-Wake Forest Baptist

Winston-Salem, North Carolina, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Scott Coleman, DO

Role: CONTACT

336-716-4498

Lynnette Harris, BSN

Role: CONTACT

336-716-8791

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Scott R Coleman, DO

Role: primary

336-716-4498

Lynnette C. Harris, BSN

Role: backup

336-716-8791

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRB00137024

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.